Biotage Moving Into Mass Directed Flash

Uppsala, Sweden, September 4, 2012 / B3C newswire / – Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces that Biotage is in late stage development with its partner Microsaic Systems plc of a fully integrated solution for Mass Directed Flash with Biotage’s flagship flash purification system Isolera™. A presentation will be held at the JASIS meeting in Makuhari, Japan on 5^th September, 2012. The new solution will become commercially available in early 2013.

“This is a game changer in flash purification that will allow chemists to significantly improve their work flow. We have high expectations on the forthcoming launch of this product that will further strengthen our purification business,” says Toshiyuki Yachi, Vice President of Marketing.

For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 422 28 1233, other areas please call +46 18 56 57 10.

About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 272 employees with sales of 428.4 MSEK in 2011. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.

For further press information from Biotage please contact:

James Churchill
Marketing Communications
Biotage GB Ltd
Distribution Way
Dyffryn Business Park
Ystrad Mynach
Hengoed, Wales CF82 7TS
United Kingdom
Tel: +44 (0)1443 811 849
Mobile: +44(0)7875484778
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it